REFERENCES
- Sibai B. M. Prevention of preeclampsia: a big disappointment. Am. J. Obstet. Gynecol. 1998; 179(5)1275–1278
- Dekker G. A., Sibai B. M. Etiology and pathogenesis of preeclampsia: current concepts. Am. J. Obstet. Gynecol. 1998; 179(5)1359–1375
- Myatt L., Miodovnik M. Prediction of preeclampsia. Semin. Perinatol. 1999; 23(1)45–57
- Sattar N., Bendomir A., Berry C., Shepherd J., Greer I. A., Packard C. J. Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosis. Obstet. Gynecol. 1997; 89(3)403–408
- Hubel C. A., McLaughlin M. K., Evans R. W., Hauth B. A., Sims C. J., Roberts J. M. Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours post partum. Am. J. Obstet. Gynecol. 1996; 174(3)975–982
- Roberts J. M., Hubel C. A. Is oxidative stress the link in the two-stage model of pre-eclampsia?. Lancet 1999; 354(9181)788–789
- Siest G., Pillot T., Régis-Bailly A., Leininger-Muller B., Steinmetz J., Galteau M. M., Visvikis S. Apolipoprotein E: an important gene and protein to follow in laboratory medicine. Clin. Chem. 1995; 41(8 Pt. 1)1068–1086
- Dallinga-Thie G. M., van Linde-Sibenius Trip M., Kock L. A., De Bruin T. W. Apolipoprotein E2/E3/E4 genotyping with agarose gels. Clin. Chem. 1995; 41(1)73–75
- Wilson P. W., Myers R. H., Larson M. G., Ordovas J. M., Wolf P. A., Schaefer E. J. Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham offspring study. JAMA, J. Am. Med. Assoc. 1994; 272(21)1666–1671
- Francoual J., Audibert F., Claise C., Chalas J., Trioche P., Frydman R., Lindenbaum A. Implication of apolipoprotein E and the l-arginine–nitric oxide system in preeclampsia. Hypertens. Pregnancy 1999; 18(3)229–237
- Vincent-Viry M., Schiele F., Gueguen R., Bohnet K., Visvikis S., Siest G. Biological variations and genetic reference values for apolipoprotein E serum concentrations: results from the STANISLAS cohort study. Clin. Chem. 1998; 44(5)957–965
- American College of Obstetricians and Gynecologists. Hypertension in Pregnancy. ACOG Technical Bulletin, ACOG, Washington, DC 1996; Vol. 219
- Zivelin A., Rosenberg N., Peretz H., Amit Y., Kornbrot N., Seligsohn U. Improved method for genotyping apolipoprotein E polymorphisms by a PCR-based assay simultaneously utilizing two distinct restriction enzymes. Clin. Chem. 1997; 43(9)1657–1659
- Nagy B., Rigo J., Fintor L., Karadi I., Toth T. Apolipoprotein E alleles in women with severe pre-eclampsia. J. Clin. Pathol. 1998; 51(4)324–325
- Cooper D. W., Hill J. A., Chesley L. C., Iverson Bryans C. Genetic control of susceptibility to eclampsia and miscarriage. Br. J. Obstet. Gynaecol. 1998; 95: 644–653
- Holzgreve W., Hahn S. Novel molecular biological approaches for the diagnosis of preeclampsia. Clin. Chem. 1999; 45(4)451–452
- Morgan L., Crawshaw S., Baker P. N., Broughton Pipkin F., Kalsheker N. Maternal and fetal angiotensinogen gene allele sharing in pre-eclampsia. Br. J. Obstet. Gynaecol. 1999; 106(3)244–251
- Salha O., Sharma V., Dada T., Nugent D., Rutherford A. J., Tomlinson A. J., Philips S., Allgar V., Walker J. J. The influence of donated gametes on the incidence of hypertensive disorders of pregnancy. Hum. Reprod. 1999; 14(9)2268–2273
- Pallaud C., Maurice M., Cheng S., Grow M., Aguillon D., Sass C., Siest G., Visvikis S. Multilocus approach to cardiovascular risk. Scand. J. Clin. Lab. Invest., Suppl. 1999; 230: 168–176
- Broughton Pipkin F. What is the place of genetics in the pathogenesis of pre-eclampsia?. Biol. Neonate 1999; 76(6)325–330